RONALD HUNT

CIK 1247851 · last filed 2026-02-20

RONALD HUNT is a corporate insider who has filed 51 SEC Form 4 insider transactions across 8 companies since 2012. The most recent filing, for RLYB, was dated Feb 20, 2026. Across all open-market trades the lifetime net is +$16.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $33.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$33.80M

Companies

8

Total Filings

51

Lifetime Open-Market Net

$16.44M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RLYB Director 1,993,911 $15.92 $31.74M $4.00M 10 2026-02-20
Iterum Therapeutics plc (ITRM) Delisted Director 268,244 $0.03 $8.0K $8.61M 18 2025-01-23
Harpoon Therapeutics, Inc. (HARP) Delisted Director 13,224 $23.01 $304.3K $20.00M 17 2024-03-11
STIM Director 1,543,962 $1.33 $2.05M $0 2 2019-04-03
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 0 $3.20 $0 -$25.28M 1 2015-03-26
Relypsa Inc (RLYP) Delisted Director 1,924,626 $2.05M 1 2013-11-20
CDE 10%+ Owner 0 $17.20 $0 $0 1 2012-08-06
Durata Therapeutics, Inc. (DRTX) Delisted Director 3,028,439 $7.06M 1 2012-07-26

Recent Filings

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-20 RLYB Grant (A) $0 EDGAR
2025-05-15 RLYB Grant (A) $0 EDGAR
2025-01-23 Iterum Therapeutics plc (ITRM) Delisted Other (J) $0 EDGAR
2025-01-06 RLYB Grant (A) $0 EDGAR
2024-08-12 Iterum Therapeutics plc (ITRM) Delisted Exer (M) +247,934 $0 EDGAR
2024-05-17 RLYB Grant (A) $0 EDGAR
2024-03-11 Harpoon Therapeutics, Inc. (HARP) Delisted Mixed −1,881,969 $0 EDGAR
2024-01-04 RLYB Grant (A) $0 EDGAR
2024-01-03 Harpoon Therapeutics, Inc. (HARP) Delisted Grant (A) +1,072 $0 EDGAR
2023-11-28 Harpoon Therapeutics, Inc. (HARP) Delisted Grant (A) +5,000 $0 EDGAR
Showing 110 of 51
Page 1 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.